Executive Summary. LigoCyte is an immuno-regulatory drug discovery and development company. The Company has assembled a solid management team with experience in drug development and commercialization and is advancing its proprietary products from the pre-clinical stage into human clinical testing. These products address the treatment and prevention of inflammatory and infectious diseases, a $95 billion market..
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.